Bone marrow aspirate concentrate, or BMAC, is still an evolving treatment—but the clinical improvements reported by many patients are giving researchers good reasons to keep studying it. This article looks at BMAC knee outcomes in randomized trials, what the procedure involves, and who may be positioned for a better result. For a complete overview, see our guide to BMAC for knee osteoarthritis.
BMAC knee outcomes: what randomized studies are finding
A 2024 systematic review examined eight randomized studies with 937 patients. Across the studies, people receiving BMAC experienced significant improvement in pain and function beginning about one month after treatment. At six and twelve months, pain results favored BMAC over hyaluronic acid, although the difference was not large enough to clearly exceed the threshold for a clinically important advantage.
That nuance matters. BMAC did not prove superior to every other injection, but it did produce meaningful improvement from baseline without a signal of more serious adverse events.
What better BMAC knee outcomes can mean
For a patient, a successful result may be returning to nine holes of golf, taking the stairs with greater confidence, walking the dog farther, or delaying a more invasive decision while remaining active.
A prospective study following people with moderate knee arthritis for two years also reported improvements in pain, function, and satisfaction. These results do not prove that BMAC regrows cartilage, but they do show why patients and clinicians remain interested.
Who may be positioned for a better result?
Early and moderate arthritis generally offers more opportunity than a joint with severe deformity. A careful examination, weight-bearing X-rays, realistic goals, and a rehabilitation plan help identify patients most likely to benefit.
What is BMAC?
Bone marrow aspirate concentrate is made from your own bone marrow, usually drawn from the back of the pelvic bone under local anesthetic. The sample is spun to concentrate cells and growth factors, then injected into the knee, usually on the same day and often with imaging guidance.
BMAC contains a small number of mesenchymal stem or stromal cells along with many other cell types. That is why it is often marketed as stem cell therapy. Our stem cell therapy guide explains the different products that share that label.
What to expect from the procedure
- **Harvest:** the skin over the pelvic bone is numbed and marrow is drawn through a needle. Soreness at the harvest site for a few days is common.
- **Processing:** the marrow is concentrated in a centrifuge while you wait.
- **Injection:** the concentrate is injected into the knee joint, ideally under ultrasound or X-ray guidance.
- **Recovery:** short-term knee soreness and swelling are common. Your provider should give you an activity and rehabilitation plan.
How BMAC for knee osteoarthritis compares with PRP
PRP is made from a simple blood draw, costs less, and has a larger body of research in knee arthritis. BMAC requires a marrow harvest and usually costs several times more. Many careful providers discuss PRP first and consider BMAC for knee osteoarthritis when there is a specific reason. See our guides to PRP for knee osteoarthritis, PRP vs. stem cells, and stem cell therapy cost.
Questions to ask before BMAC
- Where will the marrow be harvested, and what anesthesia will I have?
- How is the marrow processed, and what device do you use?
- Will the knee injection be image-guided?
- What BMAC knee outcomes have your own patients had at six and twelve months?
- What is the total cost in writing, including imaging and follow-up?
Finding a BMAC provider
Browse BMAC providers and clinics that treat knee pain and osteoarthritis in our directory. Our knee pain guide and osteoarthritis guide cover the full range of treatment options.
BMAC knee outcomes: common questions
Is BMAC the same as stem cell therapy?
Not exactly. BMAC contains some stem or stromal cells, but they are a small fraction of the cells in the concentrate. It is often marketed as stem cell therapy, so ask exactly what product a clinic is offering.
Is BMAC FDA-approved?
BMAC is not an FDA-approved drug for knee arthritis. Same-day procedures that use your own minimally processed cells fall under different FDA rules than donor stem cell products, but that is not the same as the FDA confirming that the treatment works.
Does insurance cover BMAC?
In many settings BMAC is self-pay. Ask for a written quote that includes the harvest, processing, imaging, and follow-up visits.
Does BMAC regrow cartilage?
The studies so far show improvements in pain and function, not proof that BMAC regrows cartilage. Be cautious of any clinic that promises it will.
The encouraging bottom line
BMAC is not a miracle and remains a self-pay option in many settings. Yet “still being studied” does not mean “nothing positive is happening.” Randomized trials show that many patients improve, sometimes for a year or longer. The next generation of research should clarify who benefits most and whether BMAC offers enough added value over simpler options.
Sources and further reading
This article is educational and is not medical advice.
Author: Regen Provider Guide Editorial
Get the free guide: The 9 Most Common Regenerative Treatments
What they cost, what the evidence says, and whether insurance pays - a 9-page plain-English guide for patients.